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a-Synuclein is an abundant presynaptic protein that is
associated with several biological activities, including vesicle
trafficking,
[1] maintenance of synaptic SNARE complexes and
vesicle pools,
[2,3] and regulation of dopamine metabolism.
[4]
The protein is believed to play a central role in the patho-
genesis of Parkinson s disease (PD), as evidenced by the
identification of single point mutations and gene duplication/
triplication that are causally linked to early-onset familial
PD,
[5–8] as well as its conspicuous aggregation in filamentous
inclusions associated with PD and other a-synucleinopa-
thies.
[9] Under physiological conditions in vitro, a-synuclein
exhibits properties of an intrinsically disordered protein
(IDP).
[10] Like many other IDPs,
[11] a-synuclein is known to
acquire structure upon binding to biological partners, with
strong implications for the regulation of its function and
dysfunction.
[10,12]
Biological and biophysical studies have provided strong
evidence to suggest an important link between the lipid/
membrane binding of a-synuclein and its physiological
role.
[13–16] Several NMR, EPR, CD, fluorescence, and other
biophysical studies have demonstrated that binding to
membranes and lipid mimics confers helicity on the pro-
tein,
[10,14–21] and that different conditions or binding partners
can promote the adoption of bent or extended helical
structures,
[10,14–22] although different studies have sometimes
led to contrasting views as to which of the two structures is
populated by the protein on biological membranes.
Recently, single-molecule methods have been applied in
structural studies of a-synuclein.
[16,22–25] Single-molecule
measurements avoid the signal averaging inherent in conven-
tional ensemble studies and can therefore reveal hidden
information in complex systems such as a-synuclein and other
IDPs,
[26,27] which are in general prone to structural hetero-
geneity. Our recent single-molecule FRET (smFRET;
FRET=F rster resonance energy transfer) study shed new
light on the folding characteristics of wild-type (WT; 140
residues) a-synuclein as induced by binding to small uni-
lamellar vesicles (SUVs), and membrane and lipid mimet-
ics.
[16] That study in combination with previous ensemble
thermodynamics measurements clearly established that the
bent and helical a-synuclein structures could coexist in the
presence of the same binding partners.
[10] More surprisingly,
similar dual-structural ensembles were found to be populated
not only in the presence of membranelike surfaces, but also in
association with small-molecule ligands. The aggregation
characteristics of a-synuclein appear to be dependent on the
conformational state of the monomeric protein;
[10] thus, the
complex interplay between binding and folding is directly
relevant to the disease aspects of the protein.
In this study, we probed the effects of a few key mutations
on the coupled binding and folding of a-synuclein by using a
combination of single-molecule (smFRET) and ensemble
(far-UV CD) measurements. Specifically, we examined the
PD-linked single-residue mutations A30P, A53T, and
E46K.
[5–7] We also tested a deletion mutant, aSyn 1–107, to
probe the role of the C-terminal tail in the binding–folding
behavior of a-synuclein. Our results show that the A53T,
E46K, and C-terminal-truncation mutations do not lead to
loss of the multistate folding character of the WT protein.
[10]
In contrast, the A30P mutation energetically favors popula-
tion of the bent helix conformation.
Under the solution conditions used, all the a-synuclein
mutants studied exhibited far-UV CD spectra consistent with
structures that are predominantly random coil (see Figure S1
in the Supporting Information);
[28] that is, they are intrinsi-
cally unstructured under dilute buffer conditions and in the
absence of ligands, similarly to the WT.
[10] We then employed
sodium dodecyl sulphate (SDS) as a lipid mimetic and small-
molecule amphiphilic ligand, and used it to induce ordered
structures in the WT and mutant proteins. We monitored
secondary structural changes by CD spectroscopy. Under the
experimental conditions used, the SDS critical micelle con-
centration (CMC) is approximately 1 mm.
[10] At 10 mm SDS, a
concentration at which SDS molecules exist predominantly as
spherical micelles, WT, A30P, and E46K a-synuclein had
practically identical helicities of about 63%, whereby the
percentage a-helix values were estimated on the basis of
protein far-UV CD spectra, as previously described (see
Figure S2A,B,D in the Supporting Information).
[28] By com-
parison, A53T and aSyn 1–107 were somewhat more helical
(ca. 69 and 76%, respectively; see Figure S2C,E in the
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tion to 1 mm so that SDS was mostly monomeric resulted in
increased helicity in all variants (WT, ca. 77%; A53T, ca.
87%; E46 K, ca. 80%; aSyn 1–107, ca. 93%) except for A30P
(ca. 54%).
To further study the effects of mutation on the binding-
induced folding characteristics of a-synuclein, we identified
temperature-induced conformational transitions for the dif-
ferent variants by monitoring ellipticity at 222 nm (Figure 1;
see also Figure S3A–E in the Supporting Information). The
thermal-denaturation data were analyzed by using the model
described previously
[10] (the derived unfolding-transition
thermodynamic parameters are summarized in Table S1 in
the Supporting Information). The three experimentally
observed conformational states were denoted as U, F, and I:
U is the intrinsically disordered “unfolded” state, F is the
“folded” state that is most a-helical, and I is the ordered state
exhibiting “intermediate” helicity. At an SDS concentration
of 1 mm, the A53T and E46K mutants maintained the three-
state thermal-unfolding behavior exhibited by WT a-synu-
clein (Figures 1 and 2a) and populated the F conformational
state in the temperature range investigated. Furthermore, C-
terminal truncation of the protein resulted in a minimal effect
Figure 1. Three-state thermal unfolding of WT a-synuclein, the PD-
linked A53T and E46K mutants, and a C-terminal-truncation variant
(residues 1–107). Protein-denaturation transitions were monitored by
far-UV CD spectroscopy in the presence of SDS (1 mm). Unfolding
data were collected from 0 to 1008C for all peptides except aSyn 1–
107 (0–708C), which aggregates at higher temperatures under the
experimental conditions used (see the Supporting Information for
additional details).
Figure 2. Single-molecule and ensemble characterization of the effect of the PD-linked A30P mutation on the coupled binding and folding of a-
synuclein. a,b) Thermal unfolding of WT a-synuclein (a) and the A30P mutant (b) bound to SDS monomers, as monitored at the ensemble level
by CD spectroscopy in the presence of SDS (1 mm). c) Conformational transitions of A30P a-synuclein induced by changes in ligand
concentration at room temperature, as detected at the single-molecule level by smFRET. d) Two-dimensional contour plot of previously reported
WT data
[16] for comparison with the corresponding plot for the A30P mutant in (e). e) Two-dimensional contour plot of the raw data presented in
(c). U, I, and F are different protein conformational states that exhibit characteristic FRET efficiency
[16] and helicity.
[10] U is the natively unfolded
state, I corresponds to a bent helical structure previously solved by NMR spectroscopy (1XQ8),
[18] and F is an extended a-helix structure. (See the
Supporting Information for additional details).
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suggests that the highly basic N-terminal and hydrophobic
NAC (non-Ab component of Alzheimer s disease amyloid)
regions of a-synuclein can interact with ligands/membranes
independently of the highly acidic C-terminal tail region. In
sharp contrast, A30P a-synuclein showed strikingly different
behavior consistent with a two-state transition (Figure 2b).
To further investigate this altered A30P folding, we
carried out smFRET experiments with a home-built micro-
scope system described previously.
[16] For the smFRET
measurements, donor (D; Alexa Fluor 488) and acceptor
(A; Alexa Fluor 594) FRET probes were attached to A30P a-
synuclein through the reaction of maleimide dyes with
cysteine residues incorporated by site-directed mutagenesis
at positions 7 and 84 (see the Supporting Information). The
dyes were placed at identical locations in the A30P and WT
proteins, and the A30P smFRET data (Figure 2c,e) are
entirely consistent with data from the CD measurements on
unlabeledprotein (Figure 2b), aspreviouslynoted for the WT
protein.
[10,16] Hence, the dye labeling does not significantly
perturb the folding–binding properties of the A30P mutant.
During smFRETexperiments performed over a wide range of
SDS concentrations (0–400 mm), D and A bursts were
detected simultaneously while individual labeled protein
molecules diffused freely through a diffraction-limited sub-
fL confocal detection volume. These signals were used to
calculate single-molecule FRET efficiencies (EFRET) in the
same manner as previously described.
[16]
In Figure 2c is a histogram depicting the fraction of events
plotted against measured EFRET values and ligand concen-
tration. The same data are also plotted as a 2D contour plot in
Figure 2e. For comparison, the published WT smFRET data
were replotted in an identical manner (Figure 2d).
[16] A clear
difference between the WT and A30P data is the absence of
the F-state peak at low EFRET values in the A30P data at SDS
concentrations that favor the SDS monomer (i.e., near and
below the CMC of ca. 1 mm). This result is consistent with the
thermal-denaturation data presented in Figure 2a,b and
suggests that for the A30P mutant, the bent helical structure
ofthe I stateis energeticallyfavoredover theextended helical
structure of the F state. At very high SDS concentrations (>
100 mm), at which SDS forms cylindrical micelles, population
density at low EFRET values indicates that A30P a-synuclein
may be capable of adopting more extended structures under
some conditions, although they are not preferred conforma-
tions.
The data presented herein demonstrate that in contrast
with the other mutations studied, the A30P mutation
significantly perturbs the binding–folding thermodynamics
of a-synuclein and causes the protein to inherently favor the
“I-state” bent helical structure over the “F-state” extended
helix structure. The conformational variance observed
between the protein mutants indicates that different molec-
ular disease mechanisms may be responsible for the different
early-onset variants of PD, a tentative possibility awaiting
more-direct future testing. Our data clearly show that the
A30P a-synuclein conformational properties are significantly
altered, probably as a result of the strong helix-breaking
propensity of the proline substitution. Future higher-resolu-
tion studies could reveal more-subtle conformational differ-
ences for the other mutants as well. Our A30P results, in
conjunction with previous studies that demonstrated a
reduced affinity of the A30P mutant for membranes in
vivo
[13,29] and in vitro,
[30] provide additional support for the
hypothesis that the F-state extended helical structure is the
primary membrane-binding-competent a-synuclein spe-
cies.
[16,17,21,22,31] The observed conformational propensities of
the A30P mutant may also contribute to its lowered
partitioning into lipid rafts.
[32] Furthermore, the reduced
ability of A30P a-synuclein to form the F conformation,
when taken together with the observation that the A30P
mutation decreases the rate of fibrillation (and increases the
rate of nonfibrillar oligomer formation),
[33] represents new
evidence in support of the importance of the F state as a
fibrillation intermediate.
[10] Finally, our observations of
altered A30P behavior in the absence of membrane-like
surfaces are significant because the majority of a-synuclein
expressed in vivo exists as soluble protein not bound to
membranes;
[34] therefore, the regulation of protein structure
and function in the soluble monomeric form is an important
object of study.
To conclude, this structural-thermodynamics study pres-
ents a striking demonstration of a clear, molecular conse-
quence of a PD-related mutation. Such changes to IDP
binding–folding landscapes may be linked to disease either
through loss of function or gain of toxicity. Our results are
likely to contribute to future investigations aimed at further
understanding the underlying biophysical chemistry and
molecular mechanism(s) of PD and other a-synucleinopa-
thies, as well as the native function of a-synuclein. Finally, our
study also showcases the potential of single-molecule experi-
ments to explore and reveal critical structural intricacies in
complex folding landscapes for IDPs and amyloid-forming
proteins in general.
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